In contrast, the 30 mg/kg dose achieved near maximal occupancy on all cell types assayed, with 87, 85, and 84 percent occupancy detected on splenic CD4+ T cells, tumor cells, and tumor-infiltrating CD4+ T cells, respectively (Fig 10C). This evidence concerns the gene CD4 and neoplasm.